Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narative)

v3.23.3
STOCKHOLDERS EQUITY (DEFICIT) (Details Narative) - USD ($)
9 Months Ended
Oct. 12, 2021
Sep. 30, 2023
Jan. 01, 2023
On July 5, 2023      
Purchase price   $ 16.02  
Agents fee   $ 364,997  
Exercise price   $ 0.0006  
Pre-funded warrants   78,021  
Gross proceeds of stock   $ 4,000,000  
Offering price   $ 16.0194  
Proceed from stock issuances   $ 171,666  
Common stock share issued, restricted   78,021  
2021 Incentive Plan [Member]      
Increase (decrease) in shares available for issuance     $ 78,497
Stock options, issued   232,101 166,666
Remining shares available for issuance   91,559  
Plan term 10 years    
2019 Incentive Plan [Member]      
Remaining shares   60,415  
Option issued   130,203  
Private Placement Securities [Member]      
Shares available for issuance, shares   249,688  
Exercise price   $ 16.80  
Offering price   $ 16.80  
Common stock share issued, restricted   249,688  
Minimum [Member]      
Plan term   5 years  
Maximum [Member]      
Plan term   10 years